Your browser doesn't support javascript.
loading
Recurrent PTPRB and PLCG1 mutations in angiosarcoma.
Behjati, Sam; Tarpey, Patrick S; Sheldon, Helen; Martincorena, Inigo; Van Loo, Peter; Gundem, Gunes; Wedge, David C; Ramakrishna, Manasa; Cooke, Susanna L; Pillay, Nischalan; Vollan, Hans Kristian M; Papaemmanuil, Elli; Koss, Hans; Bunney, Tom D; Hardy, Claire; Joseph, Olivia R; Martin, Sancha; Mudie, Laura; Butler, Adam; Teague, Jon W; Patil, Meena; Steers, Graham; Cao, Yu; Gumbs, Curtis; Ingram, Davis; Lazar, Alexander J; Little, Latasha; Mahadeshwar, Harshad; Protopopov, Alexei; Al Sannaa, Ghadah A; Seth, Sahil; Song, Xingzhi; Tang, Jiabin; Zhang, Jianhua; Ravi, Vinod; Torres, Keila E; Khatri, Bhavisha; Halai, Dina; Roxanis, Ioannis; Baumhoer, Daniel; Tirabosco, Roberto; Amary, M Fernanda; Boshoff, Chris; McDermott, Ultan; Katan, Matilda; Stratton, Michael R; Futreal, P Andrew; Flanagan, Adrienne M; Harris, Adrian; Campbell, Peter J.
Afiliación
  • Behjati S; Cancer Genome Project, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridgeshire, CB10 1SA, UK.
  • Tarpey PS; Department of Paediatrics, University of Cambridge, Hills Road, Cambridge, CB2 2XY, UK.
  • Sheldon H; Cancer Genome Project, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridgeshire, CB10 1SA, UK.
  • Martincorena I; The Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, OX3 9DS, UK.
  • Van Loo P; Cancer Genome Project, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridgeshire, CB10 1SA, UK.
  • Gundem G; Cancer Genome Project, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridgeshire, CB10 1SA, UK.
  • Wedge DC; Human Genome Laboratory, Department of Human Genetics, VIB and KU Leuven, B-3000 Leuven, Belgium.
  • Ramakrishna M; Cancer Genome Project, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridgeshire, CB10 1SA, UK.
  • Cooke SL; Cancer Genome Project, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridgeshire, CB10 1SA, UK.
  • Pillay N; Cancer Genome Project, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridgeshire, CB10 1SA, UK.
  • Vollan HKM; Cancer Genome Project, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridgeshire, CB10 1SA, UK.
  • Papaemmanuil E; Histopathology, Royal National Orthopaedic Hospital NHS Trust, Stanmore, Middlesex, HA7 4LP, UK.
  • Koss H; University College London Cancer Institute, Huntley Street, London, WC1E 6BT, UK.
  • Bunney TD; Cancer Genome Project, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridgeshire, CB10 1SA, UK.
  • Hardy C; Department of Oncology, Oslo University Hospital, N-0310 Oslo, Norway.
  • Joseph OR; The K.G. Jebsen Center for Breast Cancer Research, University of Oslo, N-0424 Oslo, Norway.
  • Martin S; Cancer Genome Project, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridgeshire, CB10 1SA, UK.
  • Mudie L; Institute of Structural and Molecular Biology, Division of Biosciences, University College London, London WC1E 6BT, UK.
  • Butler A; Division of Molecular Structure, MRC-National Institute for Medical Research, Mill Hill, London NW7 1AA, UK.
  • Teague JW; Institute of Structural and Molecular Biology, Division of Biosciences, University College London, London WC1E 6BT, UK.
  • Patil M; Cancer Genome Project, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridgeshire, CB10 1SA, UK.
  • Steers G; Cancer Genome Project, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridgeshire, CB10 1SA, UK.
  • Cao Y; Cancer Genome Project, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridgeshire, CB10 1SA, UK.
  • Gumbs C; Cancer Genome Project, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridgeshire, CB10 1SA, UK.
  • Ingram D; Cancer Genome Project, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridgeshire, CB10 1SA, UK.
  • Lazar AJ; Cancer Genome Project, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridgeshire, CB10 1SA, UK.
  • Little L; Department of Pathology, John Radcliffe Hospital, Oxford, OX3 9DS, UK.
  • Mahadeshwar H; Department of Pathology, John Radcliffe Hospital, Oxford, OX3 9DS, UK.
  • Protopopov A; M. D. Anderson Cancer Center, The University of Texas, 1901 East Road, Houston, Texas 77054, USA.
  • Al Sannaa GA; M. D. Anderson Cancer Center, The University of Texas, 1901 East Road, Houston, Texas 77054, USA.
  • Seth S; M. D. Anderson Cancer Center, The University of Texas, 1901 East Road, Houston, Texas 77054, USA.
  • Song X; M. D. Anderson Cancer Center, The University of Texas, 1901 East Road, Houston, Texas 77054, USA.
  • Tang J; M. D. Anderson Cancer Center, The University of Texas, 1901 East Road, Houston, Texas 77054, USA.
  • Zhang J; M. D. Anderson Cancer Center, The University of Texas, 1901 East Road, Houston, Texas 77054, USA.
  • Ravi V; M. D. Anderson Cancer Center, The University of Texas, 1901 East Road, Houston, Texas 77054, USA.
  • Torres KE; M. D. Anderson Cancer Center, The University of Texas, 1901 East Road, Houston, Texas 77054, USA.
  • Khatri B; M. D. Anderson Cancer Center, The University of Texas, 1901 East Road, Houston, Texas 77054, USA.
  • Halai D; M. D. Anderson Cancer Center, The University of Texas, 1901 East Road, Houston, Texas 77054, USA.
  • Roxanis I; M. D. Anderson Cancer Center, The University of Texas, 1901 East Road, Houston, Texas 77054, USA.
  • Baumhoer D; M. D. Anderson Cancer Center, The University of Texas, 1901 East Road, Houston, Texas 77054, USA.
  • Tirabosco R; M. D. Anderson Cancer Center, The University of Texas, 1901 East Road, Houston, Texas 77054, USA.
  • Amary MF; M. D. Anderson Cancer Center, The University of Texas, 1901 East Road, Houston, Texas 77054, USA.
  • Boshoff C; Histopathology, Royal National Orthopaedic Hospital NHS Trust, Stanmore, Middlesex, HA7 4LP, UK.
  • McDermott U; Histopathology, Royal National Orthopaedic Hospital NHS Trust, Stanmore, Middlesex, HA7 4LP, UK.
  • Katan M; Department of Pathology, John Radcliffe Hospital, Oxford, OX3 9DS, UK.
  • Stratton MR; Bone Tumour Reference Centre, Institute of Pathology, University Hospital Basel, Basel, Institute for Applied Cancer Science, Switzerland.
  • Futreal PA; Histopathology, Royal National Orthopaedic Hospital NHS Trust, Stanmore, Middlesex, HA7 4LP, UK.
  • Flanagan AM; Histopathology, Royal National Orthopaedic Hospital NHS Trust, Stanmore, Middlesex, HA7 4LP, UK.
  • Harris A; University College London Cancer Institute, Huntley Street, London, WC1E 6BT, UK.
  • Campbell PJ; Pfizer Oncology, 10555 Science Center Dr, La Jolla, CA, 92121.
Nat Genet ; 46(4): 376-379, 2014 Apr.
Article en En | MEDLINE | ID: mdl-24633157
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Fosfolipasa C gamma / Proteínas Tirosina Fosfatasas Clase 3 Similares a Receptores / Hemangiosarcoma / Neovascularización Patológica Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Nat Genet Asunto de la revista: GENETICA MEDICA Año: 2014 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Fosfolipasa C gamma / Proteínas Tirosina Fosfatasas Clase 3 Similares a Receptores / Hemangiosarcoma / Neovascularización Patológica Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Nat Genet Asunto de la revista: GENETICA MEDICA Año: 2014 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Estados Unidos